A Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Intravenous (IV) Infusion and Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Crohn's Disease

Clinical trial NCT05068284 · TERMINATED

Trial details

NCT number: NCT05068284
Sponsor: AbbVie
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2022-01-31
Primary completion: 2023-07-20
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.